Unknown

Dataset Information

0

Chemometric Outlier Classification of 2D-NMR Spectra to Enable Higher Order Structure Characterization of Protein Therapeutics.


ABSTRACT: Protein therapeutics are vitally important clinically and commercially, with monoclonal antibody (mAb) therapeutic sales alone accounting for $115 billion in revenue for 2018.[1] In order for these therapeutics to be safe and efficacious, their protein components must maintain their high order structure (HOS), which includes retaining their three-dimensional fold and not forming aggregates. As demonstrated in the recent NISTmAb Interlaboratory nuclear magnetic resonance (NMR) Study[2], NMR spectroscopy is a robust and precise approach to address this HOS measurement need. Using the NISTmAb study data, we benchmark a procedure for automated outlier detection used to identify spectra that are not of sufficient quality for further automated analysis. When applied to a diverse collection of all 252 1H,13C gHSQC spectra from the study, a recursive version of the automated procedure performed comparably to visual analysis, and identified three outlier cases that were missed by the human analyst. In total, this method represents a distinct advance in chemometric detection of outliers due to variation in both measurement and sample.

SUBMITTER: Sheen DA 

PROVIDER: S-EPMC8204403 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6343768 | biostudies-literature
| S-EPMC6995279 | biostudies-literature
| S-EPMC10419134 | biostudies-literature
| S-EPMC6066182 | biostudies-literature
| S-EPMC3663853 | biostudies-other
| S-EPMC6057790 | biostudies-literature
| S-EPMC5886730 | biostudies-literature
| S-EPMC9025983 | biostudies-literature
| S-EPMC7997113 | biostudies-literature
| S-EPMC3162047 | biostudies-literature